Treprostinil Palmitil Inhalation Powder: clinical trials recruiting now
3
Recruiting trials
4
Conditions studied
9
US states with sites
27
Countries
Phase breakdown
Phase 3 3
Conditions being studied
| Condition | Trials |
|---|---|
| Hypertension · Treprostinil Palmitil Inhalation Powder for Hypertension | 3 |
| Interstitial Lung Disease | 2 |
| Pulmonary Hypertension | 2 |
| Pulmonary Arterial Hypertension | 1 |
Recruiting trials involving Treprostinil Palmitil Inhalation Powder
- A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Common questions
How many recruiting trials involve Treprostinil Palmitil Inhalation Powder?
3 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.